Latest
The mega-IPO year that left small issuers behind
U.S. IPO proceeds set a record in 2026 while the number of deals fell about 15%. Two offerings carried the total, and new exchange rules narrowed the entry point for small issuers.

Fitness Champs Holdings Files 424B4 Prospectus for Its IPO
Fitness Champs Holdings (FCHL) filed its final 424B4 prospectus with the SEC on Nov. 20, 2026. Here is what the filing signals and what to check next.
SEC v. Meyer Global: a review of the risks inside pre-IPO share funds
The SEC alleges a private fund adviser misappropriated assets from funds holding SpaceX and other pre-IPO interests, and let one fund forfeit a nearly $3 million position.

Medline Files 424B4 Prospectus, Final Step in Its IPO
Medline Inc. filed its final 424B4 prospectus with the SEC on Nov. 19, 2026. Here is what the filing signals and which pricing terms to check in the document.
vVARDIS Files 424B4 Prospectus: What the Final IPO Document Shows
vVARDIS Holding AG filed its final 424B4 prospectus with the SEC on Nov. 16, 2026. Here is what the filing signals and what readers should check in it.
ABVC BioPharma Files 424B4 Prospectus: What the Filing Shows
ABVC BioPharma filed a final 424B4 prospectus with the SEC on Nov. 13, 2026. Here is what the filing is, what is confirmed, and what to check in its pricing pages.
424B4 Prospectus: 707 Cayman's $2.60 Best-Efforts Unit Offering
707 Cayman Holdings filed a 424B4 for up to 2 million units at $2.60 with four warrants each, sold with no underwriter or minimum after two consolidations.

424B4 Prospectus: Parabolic's $13.5M Offering Carries Warrant Resets
Parabolic Technologies filed a 424B4 prospectus for a $13.5 million unit offering with two-step warrant resets, a Nasdaq appeal and going-concern doubt.

424B4 Prospectus: Janus Living Prices $748M Follow-On at $28.50
Janus Living's 424B4 prospectus sets a $748 million follow-on at $28.50 a share on the NYSE, with proceeds earmarked for senior housing deals and revolver debt.

424B4 Prospectus: RACC Merger Values Oak Hill Bio at $160M
Research Alliance Corp III filed its 424B4 prospectus for the Oak Hill Bio merger: $160M base equity value, $55M PIPE, a $75M backstop and a Nov. 24 vote.
Megan Holdings files final 424B4 prospectus for its IPO
Megan Holdings Ltd. filed its final 424B4 prospectus with the SEC on Oct. 29, 2026. Here is what the filing signals and what to check in IPO pricing terms.

Globa Terra Acquisition Corp Files 8-K After Initial Public Offering
Globa Terra Acquisition Corp filed an 8-K on Oct. 22, 2026 tied to the closing of its initial public offering. Here is what the filing signals and what to watch.